The importance of SOCS proteins in modulating the JAK/STAT pathway has been highlighted in recent years by various studies and, in this regard, this class of proteins is emerging as a possible new therapeutic target in the treatment of inflammation-related pathologies, including inflammatory skin diseases [30,31,32]. The gene discussed is CISH; the disease is inflammatory skin disease.